Atherly D - Search Results

1

Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions.

Usuf E, Mackenzie G, Lowe-Jallow Y, Boye B, Atherly D, Suraratdecha C, Griffiths UK. Usuf E, et al. Among authors: atherly d. Vaccine. 2014 Apr 7;32(17):1975-81. doi: 10.1016/j.vaccine.2014.01.045. Epub 2014 Feb 3. Vaccine. 2014. PMID: 24503271

2

Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications.

Pecenka C, Usuf E, Hossain I, Sambou S, Vodicka E, Atherly D, Mackenzie G. Pecenka C, et al. Among authors: atherly d. BMJ Glob Health. 2021 Dec;6(12):e007211. doi: 10.1136/bmjgh-2021-007211. BMJ Glob Health. 2021. PMID: 34916274 Free PMC article.

3

The economic burden of childhood pneumococcal diseases in The Gambia.

Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C. Usuf E, et al. Among authors: atherly d. Cost Eff Resour Alloc. 2016 Feb 17;14:4. doi: 10.1186/s12962-016-0053-4. eCollection 2016. Cost Eff Resour Alloc. 2016. PMID: 26893592 Free PMC article.

4

Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.

Yeung KHT, Lin SL, Clark A, McGhee SM, Janusz CB, Atherly D, Chan KC, Nelson EAS. Yeung KHT, et al. Among authors: atherly d. Vaccine. 2021 Jan 3;39(1):45-58. doi: 10.1016/j.vaccine.2020.10.052. Epub 2020 Nov 18. Vaccine. 2021. PMID: 33221066 Free article.

5

Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.

Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK. Jauregui B, et al. Among authors: atherly d. Vaccine. 2015 May 7;33 Suppl 1(0 1):A28-33. doi: 10.1016/j.vaccine.2014.10.090. Vaccine. 2015. PMID: 25919170 Free PMC article.

6

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.

Pecenka C, Parashar U, Tate JE, Khan JAM, Groman D, Chacko S, Shamsuzzaman M, Clark A, Atherly D. Pecenka C, et al. Among authors: atherly d. Vaccine. 2017 Jul 13;35(32):3982-3987. doi: 10.1016/j.vaccine.2017.05.087. Epub 2017 Jun 13. Vaccine. 2017. PMID: 28623028 Free PMC article.

7

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.

Nonvignon J, Atherly D, Pecenka C, Aikins M, Gazley L, Groman D, Narh CT, Armah G. Nonvignon J, et al. Among authors: atherly d. Vaccine. 2018 Nov 12;36(47):7215-7221. doi: 10.1016/j.vaccine.2017.11.080. Epub 2017 Dec 6. Vaccine. 2018. PMID: 29223486 Free PMC article.

8

Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.

Diop A, Atherly D, Faye A, Lamine Sall F, Clark AD, Nadiel L, Yade B, Ndiaye M, Fafa Cissé M, Ba M. Diop A, et al. Among authors: atherly d. Vaccine. 2015 May 7;33 Suppl 1:A119-25. doi: 10.1016/j.vaccine.2014.12.065. Vaccine. 2015. PMID: 25919151

9

Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.

Rheingans R, Anderson JD 4th, Anderson B, Chakraborty P, Atherly D, Pindolia D. Rheingans R, et al. Among authors: atherly d. Vaccine. 2014 Aug 11;32 Suppl 1:A140-50. doi: 10.1016/j.vaccine.2014.05.073. Vaccine. 2014. PMID: 25091669 Free article.

10

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD. Atherly DE, et al. Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096. Vaccine. 2012. PMID: 22520139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters